Literature DB >> 26129740

The Changing Landscape of Vestibular Schwannoma Management in the United States--A Shift Toward Conservatism.

Matthew L Carlson1, Elizabeth B Habermann2, Amy E Wagie2, Colin L Driscoll3, Jamie J Van Gompel3, Jeffrey T Jacob4, Michael J Link3.   

Abstract

OBJECTIVE: To characterize the evolving management of vestibular schwannoma (VS) in the United States. STUDY
DESIGN: Retrospective analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
SETTING: SEER database. SUBJECTS AND METHODS: All patients with a diagnosis of VS were analyzed. Data were described and compared using trend analyses and univariate and multivariable logistic regression.
RESULTS: A total of 8330 patients (average age 54.7 years, 51.9% female) were analyzed. The mean incidence was approximately 1.1 per 100,000 per year and did not vary significantly across time; however, from 2004 to 2011, there was a statistically significant decrease in tumor size category at time of diagnosis (P < .01). Overall, 3982 patients (48%) received primary microsurgery, 1978 (24%) radiation therapy alone, and 2370 (29%) observation. Within the microsurgical cohort, 732 (18%) underwent subtotal resection, and of those, 98 (13.4%) received postoperative radiation therapy. Multivariable regression revealed that surgical treatment was more common in younger patients and larger tumor size categories (P < .05). Management trend analysis revealed that microsurgery was used less frequently over time (P < .0001), observation was used more frequently (P < .0001), and the pattern of radiation therapy remained unchanged. Linear regression was used to create an equation that was applied to predict future management practices. These data predict that by 2026, half of all cases of VS will be managed initially with observation.
CONCLUSION: While the incidence of VS has remained steady, tumor size at time of diagnosis has decreased over time. Within the United States there has been a clear, recent evolution in management toward observation. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2015.

Entities:  

Keywords:  acoustic neuroma; cerebellopontine angle; gamma knife radiosurgery; microsurgery; stereotactic radiosurgery; vestibular schwannoma

Mesh:

Year:  2015        PMID: 26129740     DOI: 10.1177/0194599815590105

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  46 in total

1.  Resection planning for robotic acoustic neuroma surgery.

Authors:  Kepra L McBrayer; George B Wanna; Benoit M Dawant; Ramya Balachandran; Robert F Labadie; Jack H Noble
Journal:  J Med Imaging (Bellingham)       Date:  2017-06-05

2.  Vestibular schwannoma and pituitary adenoma in the same patient: coincidence or novel clinical association?

Authors:  Matthew L Carlson; Neil S Patel; Amy E Glasgow; Elizabeth B Habermann; Brandon R Grossardt; Michael J Link
Journal:  J Neurooncol       Date:  2016-02-22       Impact factor: 4.130

Review 3.  [Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma].

Authors:  K Hamm; H-U Herold; G Surber; S Rosahl
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

4.  CyberKnife for Treatment of Vestibular Schwannoma: A Meta-analysis.

Authors:  Hossein Mahboubi; Ronald Sahyouni; Omid Moshtaghi; Kent Tadokoro; Yaser Ghavami; Kasra Ziai; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04-25       Impact factor: 3.497

5.  Risk Recall of Complications Associated with Vestibular Schwannoma Treatment.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Omid Moshtaghi; Marlon Maducdoc; Brandon M Lehrich; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2019-03-19       Impact factor: 3.497

6.  The natural history of vestibular schwannoma growth-prospective 40-year data from an unselected national cohort.

Authors:  Martin Reznitsky; Mette Marie Babiel Schmidt Petersen; Niels West; Sven-Eric Stangerup; Per Cayé-Thomasen
Journal:  Neuro Oncol       Date:  2021-05-05       Impact factor: 12.300

Review 7.  [Vestibular schwannoma - management and microsurgical results].

Authors:  S Rosahl; D Eßer
Journal:  HNO       Date:  2017-05       Impact factor: 1.284

8.  Single Institutional Experience With Observing 564 Vestibular Schwannomas: Factors Associated With Tumor Growth.

Authors:  Jacob B Hunter; David O Francis; Brendan P O'Connell; Edmond K Kabagambe; Marc L Bennett; George B Wanna; Alejandro Rivas; Reid C Thompson; David S Haynes
Journal:  Otol Neurotol       Date:  2016-12       Impact factor: 2.311

9.  Malignization of a vestibular schwannoma 13 years after radiation therapy.

Authors:  S Simmermacher; D Vordermark; T Kegel; C Strauss
Journal:  HNO       Date:  2017-08       Impact factor: 1.284

10.  Postoperative Complications and Readmission Rates Following Surgery for Cerebellopontine Angle Schwannomas.

Authors:  Hossein Mahboubi; Yarah M Haidar; Omid Moshtaghi; Kasra Ziai; Yaser Ghavami; Marlon Maducdoc; Harrison W Lin; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2016-10       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.